VIVO BIO TECH LTD. - 511509 - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated Financial Results For The Fourth Quarter And Year Ended March 31, 2023
VIVO BIO TECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results for the Fourth Quarter and Year Ended March 31, 2023 VIVO BIO TECH LTD. - 511509 - Annual Secretarial Compliance Report For The Year Ended March 31, 2023
Vivo Bio Tech Limited has submitted with the Exchange Annual Secretarial Compliance Report for the year ended March 31, 2023. VIVO BIO TECH LTD. - 511509 - Certificate Under Regulation 40(9) Read With Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2023
Vivo Bio Tech Limited has submitted with the exchange the certificate issued by Company Secretary in Practice under Regulation 40(9) read with Regulation 40 (10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the period from April 01, 2022 to March 31, 2023. VIVO BIO TECH LTD. - 511509 - Compliance Certificate For The Year Ended March 31, 2023
Vivo Bio Tech Limited has submitted with the exchange the Compliance Certificate for the year ended March 31, 2023 in complinace with Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015. VIVO BIO TECH LTD. - 511509 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Vivo Bio Tech Limited has submitted with the exchange the certificate received from M/s. Aarthi Consultants Private Limited (Registrar and Share Transfer Agent), for the period from January 01, 2023 to March 31, 2023 under SEBI (Depositories and Participants) Regulations, 2018. VIVO BIO TECH LTD. - 511509 - Clarification On Price Movement
Vivo Bio Tech Limited has submitted with the exchange the Clarification on Price Movement in connection with email received from BSE on April 10, 2023. VIVO BIO TECH LTD. - 511509 - Clarification sought from Vivo Bio Tech Ltd
The Exchange has sought clarification from Vivo Bio Tech Ltd on April 10, 2023 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited. VIVO BIO TECH LTD. - 511509 - Announcement under Regulation 30 (LODR)-Resignation of Director
Vivo Bio Tech Limited has informed the exchange that, Mr. Sunder Kanaparthy (DIN: 00914869), Independent Director has resigned from the Board of Directors w.e.f April 01, 2023 due to his pre-occupations. VIVO BIO TECH LTD. - 511509 - Closure of Trading Window
Vivo Bio Tech Limited has informed the exchange that pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 and Company's Internal Code of Conduct to Regulate, Monitor and Report Trading by Directors, Promoters and Designated Persons of the Company, the Trading Window for dealing in the securities of the Company shall remain Closed for all insiders including Designated Persons and their immediate relatives from April 01, 2023 till the end of 48 hours after the declaration of the Audited Financial Results of the Company for the fourth quarter and year ended March 31, 2023. VIVO BIO TECH LTD. - 511509 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Vivo Bio Tech Limited has submitted with the exchange the copies of advertisement issued in newspapers on February 15, 2023, in ''Financial Express'' in English Language and in ''Nava Telangana'' in Telugu Language, with respect to the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2022.